Lidocaine Viscous

Product NDC: 55700-632
11-digit product format: 557000632
Labeler code: 55700
Product ID: 55700-632_2d517cad-e720-4ce4-8626-316a6a5e22da
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine Hydrochloride
Dosage form: SOLUTION
Route: ORAL; TOPICAL
Labeler: Lake Erie Medical DBA Quality Care Products LLC
Application: ANDA088802
Marketing category: ANDA
Marketing start: 2018-05-25
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE
Active strength: 20 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	55700-632		D	Discontinued by firm		2026-08-10
excluded package	package	55700-632	55700-632-00	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55700-632-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55700-632-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55700-632-00	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55700-632-00	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55700-632-00	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55700-632-00	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55700-632-00	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55700-632-00	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55700-632-00	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	55700-632-00	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55700-632-00	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55700-632-00	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A088802-001	LIDOCAINE VISCOUS	LIDOCAINE HYDROCHLORIDE	2%	SOLUTION / ORAL	AT		1985-04-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A088802-001	AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A088802-001	LIDOCAINE VISCOUS	2%	SOLUTION / ORAL	AT	1985-04-26	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A088802-001	AT	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A088802-001	AT	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A088802-001	AT	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A088802-001	AT	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A088802-001	AT	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A088802-001	AT	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A088802-001	AT	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A088802-001	AT	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A088802-001	AT	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A088802-001	AT	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A088802-001	AT	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A088802-001	AT	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A088802-001	AT	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A088802-001	AT	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A088802-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A088802-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A088802-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A088802-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A088802-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A088802-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A088802-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A088802-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A088802-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A088802-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A088802-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A088802-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A088802-001	AT	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A088802-001	AT	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A088802-001	AT	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A088802-001	AT	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A088802-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A088802-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A088802-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A088802-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A088802-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A088802-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A088802-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A088802-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A088802-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A088802-001	AT	1	`cb3db0bc1861…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55700-632-00	ML - Milliliter	55700-632	64056c07-ae2e-4ee6-991a-45a8abc77a8b	1	2018-06-11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Viscous	LIDOCAINE HYDROCHLORIDE	REMEDYREPACK INC.	6f8d20d2-6a91-4a5b-bfe8-f1baada38442	2026-01-16	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088802 application number: ANDA088802
Lidocaine Viscous	LIDOCAINE HYDROCHLORIDE	Hikma Pharmaceuticals USA Inc.	79b42076-359d-4258-b1d8-f40e67ac5424	2024-12-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088802 application number: ANDA088802
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	0050d05a-b8e9-c544-e063-6294a90a0243	2024-02-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088802 application number: ANDA088802
Lidocaine Viscous	LIDOCAINE HYDROCHLORIDE	A-S Medication Solutions	75f2d450-aa2e-4a09-b4f7-4fcbcbf8b205	2023-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088802 application number: ANDA088802